Drug Discovery

The WHO called for an effective maternal GBS vaccine that could protect infants through transplacental transfer of maternal antibodies.

Technological advances are opening up new drug development opportunities for rare diseases.

Delali Attipoe at the DNDi explains why we need an R&D model attuned to the needs of forgotten patients.

Research and development in sleep-wake disorders has been asleep on its feet

Sitting Down With … Piper Trelstad, Head of CMC, The Bill & Melinda Gates Medical Research Institute

What does the future hold for pharma? Audrey Greenberg and Jon Zwinski give their views.

What trends and disruptions will shape the future of pharma? West’s Anya Harry gives her view.

How the pharma industry can help tackle the opioid crisis and advance treatments

Here’s how an mRNA-based approach can overcome the development challenges of designing protein therapeutics.

Researchers use AI to reprogram glioblastoma cancer cells